Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months-Reference-Cited by-同舟云学术

Ultrasonographic evidence of joint thickening reversibility in acromegalic patients treated with lanreotide for 12 months

Published:1999-11 Issue:5 Volume:51 Page:611-618
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clinical Endocrinology

Author:

Colao Annamaria,Marzullo Paolo,Vallone Gianfranco,Giaccio Assunta,Ferone Diego,Rossi Eugenio,Scarpa Raffaele,Smaltino Francesco,Lombardi Gaetano

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.1999.00851.x/fullpdf

Reference29 articles.

1. The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly;Al-Maskari;Clinical Endocrinology,1996

2. Acromegalic arthropathy and sleep apnea;Barkan;Journal of Endocrinology,1997

3. Acromegalic arthropathy;Bluestone;Annals of Rheumatic Diseases,1971

4. Three years follow-up of acromegalic patients treated with intramuscular slow-release lanreotide;Caron;Journal of Clinical Endocrinology and Metabolism,1997

5. The effect of growth hormone on established cartilage lesions;Chrisman;Clinical Orthopedics,1975

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring potential influencing factors of inadherence to specialist aftercare and long-term medication in patients with acromegaly;Pituitary;2024-05-24

2. Joint pain, physical function, and balance self-confidence in acromegaly versus nonfunctioning pituitary adenoma patients;European Journal of Endocrinology;2023-07-20

3. Metabolic Bone Disease;Imaging of the Foot and Ankle;2023

4. Clinical and radiographic assessment of peripheral joints in controlled acromegaly;Pituitary;2022-06-20

5. Pedabarography May Play a Role in Foot Plantar Scanning in Acromegaly;International Journal of Clinical Practice;2022-05-17